Objectif A large number of implant is available for osseous repair, and fresh autogenous bone grafts are preferred because of their compatibility. However there are several disadvantages associated with the use of autogenous bone, especially due to the limited supply at any one donor site and the added morbidity associated with its harvest (wound problems, permanent sensory loss...). This project aims to develop a new polyurethane polymer as a hard tissue adhesive for fractured bone The new biomaterial will ensure a best security compared with current procedures, as it eliminates the risk of transmission diseases due to foreign bone and the drawbacks linked to multi-chirurgical procedures.The following R&D actions will be carried out:- To examine that the biomaterial comes into contact with tissues and biological fluids- To ensure that the repositioned bone fragments adhered well to their original sites- To develop a controllable degradative process: study of the mode of degradation and excretion of the biomaterial- To promote bone reconstruction (osteoinduction). It will be also necessary to develop a new approach, procedures and surgery technique. Champ scientifique medical and health sciencesclinical medicinesurgerynatural scienceschemical sciencespolymer sciencespolyurethaneengineering and technologyindustrial biotechnologybiomaterials Programme(s) FP5-GROWTH - Programme for research technological development and demonstration on "Competitive and sustainable growth 1998-2002" Thème(s) 1.1.3.-5. - RTD Activities of a Generic Nature : materials and their technologies for production and transformation and new and improved materials and production technologies in the steel field Appel à propositions Data not available Régime de financement EAW - Exploratory awards Coordinateur CURASAN PHARMA GMBH Contribution de l’UE Aucune donnée Adresse Lindigstrasse 4 63801 KLEINOSTHEIM Allemagne Voir sur la carte Coût total Aucune donnée Participants (1) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire STATICE SANTE S.A. France Contribution de l’UE Aucune donnée Adresse Rue Thomas Edison 9, Zone Industrielle des Tiller 25000 BESANCON Voir sur la carte Coût total Aucune donnée
